These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

721 related items for PubMed ID: 17944268

  • 1. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY, Boivin G, Roberts N.
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [Abstract] [Full Text] [Related]

  • 2. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
    Tashiro M, McKimm-Breschkin JL, Saito T, Klimov A, Macken C, Zambon M, Hayden FG, Neuraminidase Inhibitor Susceptibility Network.
    Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
    [Abstract] [Full Text] [Related]

  • 3. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Abed Y, Nehmé B, Baz M, Boivin G.
    Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743
    [Abstract] [Full Text] [Related]

  • 4. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
    Duwe S, Schweiger B.
    J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
    Ferraris O, Kessler N, Lina B.
    Antiviral Res; 2005 Oct; 68(1):43-8. PubMed ID: 16125799
    [Abstract] [Full Text] [Related]

  • 6. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y, Baz M, Boivin G.
    J Infect Dis; 2009 Jan 15; 199(2):180-3. PubMed ID: 19046066
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X, Zhou J, Zhang Y, Wu J, Zhang F, Li Z, Zhang Y, Bi S, Shu Y, Wang Y.
    Biochem Biophys Res Commun; 2009 Dec 25; 390(4):1305-8. PubMed ID: 19879239
    [Abstract] [Full Text] [Related]

  • 13. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
    Ikematsu H, Kawai N.
    Expert Rev Anti Infect Ther; 2011 Oct 25; 9(10):851-7. PubMed ID: 21973296
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.
    Gubareva LV.
    Virus Res; 2004 Jul 25; 103(1-2):199-203. PubMed ID: 15163510
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.